Side effects of non-steroidal anti rheumatic drugs: A survey in Austria;Unerwünschte wirkungen unter nichtsteroidalen antiphlogistika. Eine prävalenzstudie aus Österreich

Wiener Klinische Wochenschrift

Volumn 115, Issue 1-2, 2003, Pages 41-46

  Kolarz, Gernot ^a,c   Mayrhofer, Franz ^a   Neumann, Kurt ^b   Singer, Franz ^a  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b E I S GmbH   (Austria)

^c NONE   (Austria)

Author keywords

Gastrointestinal risk; NSAID

Indexed keywords

ANTIRHEUMATIC AGENT; DICLOFENAC; FAMOTIDINE; IBUPROFEN; MELOXICAM; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ARTICLE; AUSTRIA; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DISEASE SEVERITY; DYSPEPSIA; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE;

EID: 0344089311     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03040271     Document Type: Article

References (12)

1. Gabriel SE, Jaakkimainen L, Bombardier C (1991) Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a metaanalysis. Ann Intern Med 115: 787-796
2. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA (1991) Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 114: 257-263
3. Singh G, Rosen Ramey D (1998) NSAID-induced gastrointestinal complications: the ARAMIS perspective 1997-Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol [Suppl] 51: 8-16
4. Singh G (2000) Gastrointestinal complications of prescription and over-the-counter nonsteroidal antiinflammatory drugs: a view from the ARAMIS database. Am J Ther 7: 121
5. Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 340: 1888-1899
6. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature 231:235-239
7. Needleman P, Turk J, Jaschik BA, Morrison AR, Lefkowith JB (1986) Arachidonic acid metabolism. Ann Rev Biochem 55: 69-102
8. Rainer F, Pongratz R, Bröll J, Czurda R, Dunky A, Graninger W, Leeb B, Mayrhofer F, Mur E, Pilz I, Siegmeth W, Singer F, Thumb N, Ulreich A (2001) Magenschutz bei Therapie mit nichtsteroidalen Antirheumatika. In: Thumb N et al (Hrsg) Praktische Rheumatologie. Springer, Wien New York, S 593-594
9. Garcia RL, Jick H (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 343: 769-772
10. Kolarz G, Ortner P, Siegmeth W, Singer F, Thumb N (1988) Rheumatische Erkrankungen in Österreich. Epidemiologische Untersuchung von 2911 Patienten. Therapiewoche Österreich 3: 853-858
11. Singer F, Kolarz G, Siegmeth W, Thumb N, Wottawa A (1992) Rheumatische Erkrankungen in Österreich - Analyse bei 725 niedergelassenen Ärzten. Akt Rheumatol 17: 156-161
12. Kurowski M (1990) SPALA-Sicherheitsprofil von Antirheumatika bei Langzeitanwendung. Deutsches Ärzteblatt Ärztliche Mitteilungen 37: 1632-1638